table of content
1 Study Coverage
1.1 Human Coagulation Factor IX Product Introduction
1.2 Global Human Coagulation Factor IX Outlook 2017 VS 2022 VS 2028
1.2.1 Global Human Coagulation Factor IX Sales in US$ Million for the Year 2017-2028
1.2.2 Global Human Coagulation Factor IX Sales in Volume for the Year 2017-2028
1.3 United States Human Coagulation Factor IX Outlook 2017 VS 2022 VS 2028
1.3.1 United States Human Coagulation Factor IX Sales in US$ Million for the Year 2017-2028
1.3.2 United States Human Coagulation Factor IX Sales in Volume for the Year 2017-2028
1.4 Human Coagulation Factor IX Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Human Coagulation Factor IX in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Human Coagulation Factor IX Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Human Coagulation Factor IX Market Dynamics
1.5.1 Human Coagulation Factor IX Industry Trends
1.5.2 Human Coagulation Factor IX Market Drivers
1.5.3 Human Coagulation Factor IX Market Challenges
1.5.4 Human Coagulation Factor IX Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Human Coagulation Factor IX Market Segment by Type
2.1.1 AHGB
2.1.2 AHFB
2.1.3 Others
2.2 Global Human Coagulation Factor IX Market Size by Type
2.2.1 Global Human Coagulation Factor IX Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Human Coagulation Factor IX Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Human Coagulation Factor IX Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Human Coagulation Factor IX Market Size by Type
2.3.1 United States Human Coagulation Factor IX Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Human Coagulation Factor IX Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Human Coagulation Factor IX Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Human Coagulation Factor IX Market Segment by Application
3.1.1 Hospital
3.1.2 Personal Clinic
3.1.3 Others
3.2 Global Human Coagulation Factor IX Market Size by Application
3.2.1 Global Human Coagulation Factor IX Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Human Coagulation Factor IX Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Human Coagulation Factor IX Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Human Coagulation Factor IX Market Size by Application
3.3.1 United States Human Coagulation Factor IX Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Human Coagulation Factor IX Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Human Coagulation Factor IX Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Human Coagulation Factor IX Competitor Landscape by Company
4.1 Global Human Coagulation Factor IX Market Size by Company
4.1.1 Top Global Human Coagulation Factor IX Manufacturers Ranked by Revenue (2021)
4.1.2 Global Human Coagulation Factor IX Revenue by Manufacturer (2017-2022)
4.1.3 Global Human Coagulation Factor IX Sales by Manufacturer (2017-2022)
4.1.4 Global Human Coagulation Factor IX Price by Manufacturer (2017-2022)
4.2 Global Human Coagulation Factor IX Concentration Ratio (CR)
4.2.1 Human Coagulation Factor IX Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Human Coagulation Factor IX in 2021
4.2.3 Global Human Coagulation Factor IX Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Human Coagulation Factor IX Manufacturing Base Distribution, Product Type
4.3.1 Global Human Coagulation Factor IX Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Human Coagulation Factor IX Product Type
4.3.3 Date of International Manufacturers Enter into Human Coagulation Factor IX Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Human Coagulation Factor IX Market Size by Company
4.5.1 Top Human Coagulation Factor IX Players in United States, Ranked by Revenue (2021)
4.5.2 United States Human Coagulation Factor IX Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Human Coagulation Factor IX Sales by Players (2020, 2021 & 2022)
5 Global Human Coagulation Factor IX Market Size by Region
5.1 Global Human Coagulation Factor IX Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Human Coagulation Factor IX Market Size in Volume by Region (2017-2028)
5.2.1 Global Human Coagulation Factor IX Sales in Volume by Region: 2017-2022
5.2.2 Global Human Coagulation Factor IX Sales in Volume Forecast by Region (2023-2028)
5.3 Global Human Coagulation Factor IX Market Size in Value by Region (2017-2028)
5.3.1 Global Human Coagulation Factor IX Sales in Value by Region: 2017-2022
5.3.2 Global Human Coagulation Factor IX Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Human Coagulation Factor IX Market Size YoY Growth 2017-2028
6.1.2 North America Human Coagulation Factor IX Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Human Coagulation Factor IX Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Human Coagulation Factor IX Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Human Coagulation Factor IX Market Size YoY Growth 2017-2028
6.3.2 Europe Human Coagulation Factor IX Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Human Coagulation Factor IX Market Size YoY Growth 2017-2028
6.4.2 Latin America Human Coagulation Factor IX Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Human Coagulation Factor IX Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Human Coagulation Factor IX Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 Grifols
7.1.1 Grifols Corporation Information
7.1.2 Grifols Description and Business Overview
7.1.3 Grifols Human Coagulation Factor IX Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Grifols Human Coagulation Factor IX Products Offered
7.1.5 Grifols Recent Development
7.2 Biogen
7.2.1 Biogen Corporation Information
7.2.2 Biogen Description and Business Overview
7.2.3 Biogen Human Coagulation Factor IX Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Biogen Human Coagulation Factor IX Products Offered
7.2.5 Biogen Recent Development
7.3 Octapharma
7.3.1 Octapharma Corporation Information
7.3.2 Octapharma Description and Business Overview
7.3.3 Octapharma Human Coagulation Factor IX Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Octapharma Human Coagulation Factor IX Products Offered
7.3.5 Octapharma Recent Development
7.4 Baxter
7.4.1 Baxter Corporation Information
7.4.2 Baxter Description and Business Overview
7.4.3 Baxter Human Coagulation Factor IX Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Baxter Human Coagulation Factor IX Products Offered
7.4.5 Baxter Recent Development
7.5 Bayer
7.5.1 Bayer Corporation Information
7.5.2 Bayer Description and Business Overview
7.5.3 Bayer Human Coagulation Factor IX Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Bayer Human Coagulation Factor IX Products Offered
7.5.5 Bayer Recent Development
7.6 CSL
7.6.1 CSL Corporation Information
7.6.2 CSL Description and Business Overview
7.6.3 CSL Human Coagulation Factor IX Sales, Revenue and Gross Margin (2017-2022)
7.6.4 CSL Human Coagulation Factor IX Products Offered
7.6.5 CSL Recent Development
7.7 Novo Nordisk
7.7.1 Novo Nordisk Corporation Information
7.7.2 Novo Nordisk Description and Business Overview
7.7.3 Novo Nordisk Human Coagulation Factor IX Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Novo Nordisk Human Coagulation Factor IX Products Offered
7.7.5 Novo Nordisk Recent Development
7.8 Greencross
7.8.1 Greencross Corporation Information
7.8.2 Greencross Description and Business Overview
7.8.3 Greencross Human Coagulation Factor IX Sales, Revenue and Gross Margin (2017-2022)
7.8.4 Greencross Human Coagulation Factor IX Products Offered
7.8.5 Greencross Recent Development
7.9 Kedrion
7.9.1 Kedrion Corporation Information
7.9.2 Kedrion Description and Business Overview
7.9.3 Kedrion Human Coagulation Factor IX Sales, Revenue and Gross Margin (2017-2022)
7.9.4 Kedrion Human Coagulation Factor IX Products Offered
7.9.5 Kedrion Recent Development
7.10 BPL
7.10.1 BPL Corporation Information
7.10.2 BPL Description and Business Overview
7.10.3 BPL Human Coagulation Factor IX Sales, Revenue and Gross Margin (2017-2022)
7.10.4 BPL Human Coagulation Factor IX Products Offered
7.10.5 BPL Recent Development
7.11 Hualan Bio
7.11.1 Hualan Bio Corporation Information
7.11.2 Hualan Bio Description and Business Overview
7.11.3 Hualan Bio Human Coagulation Factor IX Sales, Revenue and Gross Margin (2017-2022)
7.11.4 Hualan Bio Human Coagulation Factor IX Products Offered
7.11.5 Hualan Bio Recent Development
7.12 RAAS
7.12.1 RAAS Corporation Information
7.12.2 RAAS Description and Business Overview
7.12.3 RAAS Human Coagulation Factor IX Sales, Revenue and Gross Margin (2017-2022)
7.12.4 RAAS Products Offered
7.12.5 RAAS Recent Development
7.13 Pfizer
7.13.1 Pfizer Corporation Information
7.13.2 Pfizer Description and Business Overview
7.13.3 Pfizer Human Coagulation Factor IX Sales, Revenue and Gross Margin (2017-2022)
7.13.4 Pfizer Products Offered
7.13.5 Pfizer Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Human Coagulation Factor IX Industry Chain Analysis
8.2 Human Coagulation Factor IX Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Human Coagulation Factor IX Distributors
8.3 Human Coagulation Factor IX Production Mode & Process
8.4 Human Coagulation Factor IX Sales and Marketing
8.4.1 Human Coagulation Factor IX Sales Channels
8.4.2 Human Coagulation Factor IX Distributors
8.5 Human Coagulation Factor IX Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
